Search results - 81 results
Susceptibility of Mammals to Highly Pathogenic Avian Influenza: A Qualitative Risk Assessment From the Belgian Perspective
epidemiology Influenza A virus Mammals public health Risk Assessment Transmission Abstract: he world experienced a huge number of outbreaks of highly pathogenic avian influenza (HPAI) in birds, which could ...
be.Prepared: Setting up a cloud-based bioinformatics platform and coupled NRC usability platform for integrated genomic-epidemiological analysis at a national level
Azure cloud. It processes pseudonymized microbial WGS data (supporting both Illumina and nanopore sequencing), including removal of human DNA and extensive quality control, and runs state-of-the-art ...
Susceptibility of Mammals to Highly Pathogenic Avian Influenza: A Qualitative Risk Assessment From the Belgian Perspective.
world experienced a huge number of outbreaks of highly pathogenic avian influenza (HPAI) in birds, which could represent one of the largest registered epidemics of infectious disease in food-producing ...
Impact of extreme weather events on the occurrence of infectious diseases in Belgium from 2011 to 2021.
J Med Microbiol, Volume 73, Issue 7 (2024) Keywords: Belgium Borrelia burgdorferi Communicable Diseases Extreme Weather Gastroenteritis Humans incidence Rain Streptococcus pyogenes Temperature Weather ...
be.Prepared to increase Belgian integration of health data as a way of strengthening preparedness for infectious diseases
Genomics Infectious diseases national reference centre for human microbiology Pandemic preparedness public health Surveillance Whole genome sequencing (WGS) Abstract: The Belgian Preparedness Architecture ...
Excess mortality in Europe coincides with peaks of COVID-19, influenza and respiratory syncytial virus (RSV), November 2023 to February 2024.
COVID-19 Europe Humans Influenza, Human Respiratory Syncytial Virus Infections Respiratory Syncytial Virus, Human Seasons Abstract: Since the end of November 2023, the European Mortality Monitoring Network ...
Effectiveness of XBB.1.5 Monovalent COVID-19 Vaccines During a Period of XBB.1.5 Dominance in EU/EEA Countries, October to November 2023: A VEBIS-EHR Network Study.
Anthony; Bacci, Sabrina; Kissling, Esther; Nunes, Baltazar; VEBIS‐EHR Working Group Source: Influenza Other Respir Viruses, Volume 18, Issue 4 (2024) Keywords: Aged Aged, 80 and over COVID-19 COVID-19 ...
Regulatory workshop on challenge strain development and GMP manufacture- A stakeholder meeting report.
Influenza Vaccines Influenza, Human Viruses Abstract: Within the Innovative Health Initiative (IHI) Inno4Vac CHIMICHURRI project, a regulatory workshop was organised on the development and manufacture of ...
Vaccine effectiveness against influenza hospitalisation in adults during the 2022/2023 mixed season of influenza A(H1N1)pdm09, A(H3N2) and B circulation, Europe: VEBIS SARI VE hospital network.
SARI Surveillance Network (BelsariNet) Source: Influenza Other Respir Viruses, Volume 18, Issue 2 (2024) Keywords: Adult Case-Control Studies Europe Hospitalization hospitals Humans Influenza A Virus, ...
Monitoring COVID-19 vaccine effectiveness against COVID-19 hospitalisation and death using electronic health registries in ≥65 years old population in six European countries, October 2021 to November 2022.
Anthony; Nicolay, Nathalie; Monge, Susana; VEBIS-Lot4 working group Source: Influenza Other Respir Viruses, Volume 17, Issue 11 (2023) Keywords: Aged COVID-19 COVID-19 Vaccines Electronics Hospitalization ...